Publications

5891 Results

Therapeutic strategies for combined-modality therapy of locally advanced non-small cell lung cancer: rationale for consolidation docetaxel therapy

Authors
DR Gandara;E Vallieres;LE Gaspar;K Kelly;KS Albain;RS Herbst Jr;PN Lara Jr;P Mack;PH Gumerlock;JJ Crowley
Journal / Conference
Clinical Lung Cancer 7 Suppl 3:S93-97
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0023, S0220, SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9504

Phase III study of doxorubcin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer: results of North American Breast Cancer Intergroup Trial E1199

Authors
JA Sparano;M Wang;S Martino;V Jones;EA Perez;TJ Saphner;AC Wolff;GW Sledge;WC Wood;NE Davidson
Journal / Conference
Proceedings of the San Antonio Breast Cancer Symposium 2005, abstract #48
Year
2005
Research Committee(s)
Breast
Study Number(s)
E1199

Chemoprevention of melanoma: theoretical and practical considerations

Authors
MF Demierre;VK Sondak
Journal / Conference
Cancer Control 12(4):219-222
Year
2005
Research Committee(s)
Melanoma

Cutaneous melanoma: pathogenesis and rationale for chemoprevention

Authors
MF Demierre;VK Sondak
Journal / Conference
Critical Reviews in Oncology and Hematology 53(3):225-239
Year
2005
Research Committee(s)
Melanoma

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma PMID16356309

Authors
A Venook;C Blanke;D Niedzwiecki;HJ Lenz;J Taylor;D Hollis;S Sutherland;R Goldberg
Journal / Conference
Clinical Colorectal Cancer 5(4):292-294
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Plasma markers of tumor hypoxia-angiogenesis as predictors of therapeutic response

Authors
P Mack;PH Gumerlock;PN Lara;QT Le;JA Longmate;K Chansky;J Crowley;D Gandara
Journal / Conference
Proc Amer Assoc Cancer Res, Vol. 46, abstr #1140
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0003

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13

Authors
WP Peters;GL Rosner;JJ Vredenburgh;EJ Shpall;M Crump;PG Richardson;MW Schuster;LB Marks;C Cirrincione;L Norton;IC Henderson;RL Schilsky;DD Hurd
Journal / Conference
Journal of Clinical Oncology 23(10):2191-200
Year
2005
Research Committee(s)
Breast
Study Number(s)
SWOG-9114 (INT-0163) (CALGB-9082)

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741

Authors
T Delaunoit;SR Alberts;DJ Sargent;E Green;R Goldberg;J Krook;C Fuchs;RK Ramanathan;SK Williamson;RF Morton;BP Findlay
Journal / Conference
Annals of Oncology Mar;16(3):425-429
Year
2005
Research Committee(s)
Gastrointestinal
PMC
PMID15677624
Study Number(s)
N9741

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;J Benedetti;JL Abbruzzese;B Ardalan;JW Goodwin;SP Balcerzak;W Samlowski;HJ Lenz;JS Macdonald
Journal / Conference
Investigational New Drugs 22:335-341
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9100

Implementation of the prostate cancer prevention trial (PCPT)

Authors
PJ Goodman;CM Tangen;JJ Crowley;SM Carlin;A Ryan;CA Coltman, Jr.;LG Ford;IM Thompson
Journal / Conference
Controlled Clinical Trials 2:203-222
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217